Trees are easier to cut than genes. But with both, in theory, a pandemic can be unleashed. Deforesting and destroying ecosystems We make it easier for animal pathogens to jump on humans. But it is also true that we can know in great detail the source code in which the entrails of new viruses are written. Your genes. And manipulate them.
In Lluis Montolius laboratory, at the CNB-CSIC, they have been tracking the revolutionary CRISPR genetic editing technique for years. A system that allows cut and paste pieces of the genome of a living being with enormous precision, and whose discovery we owe to the Spanish Francis Mojica.
They are now developing this tool to see if it can be useful in destroying the RNA strands of coronaviruses and, therefore, prevent SARS-CoV-2 from replicating in the body. It would be the first time that such a drug is developed. Basically using the smallest scissors in the universe.
Lets start with one of the most common applications of CRISPR: making custom animals and plants. It has been done for about four years relatively regularly in research laboratories.
Mouse | Pests Mice Rats (CC-BY)
Despite the fact that the technique became world famous for the daring of Dr. He Jiankui, in 2018, to manufacture three children edited using this technique something completely illegal CRISPR is useful to make animal models.
The mouse is the classic animal model with which to experiment from antiviral drugs to vaccines. In the case of SARS-CoV-2, Mice are not infectious because they lack the ACE2 receptor that allows the virus to enter cells.
CRISPR is the technique by which, illegally, three Chinese babies were genetically edited to avoid developing AIDS. But it is common in other everyday laboratory uses.
So there are already several laboratories that are developing humanized mice with CRISPR. Human genes or parts thereof are cut and pasted into the genome of a future rodent, almost before it is an embryo.
The mouse that is born will already be able to have those receptors typical of humans (and some other animals) so that, at that level, they look a bit more similar. The next step is to no longer infect the mice. But cure them.
The coronavirus genome is RNA, explains Montoliu. If we have a CAS protein that we can program to cut RNA, why dont we target it to cut the coronavirus genome? And we are directly attacking the heart, the genetic material of that coronavirus, explains the researcher.
The CNB-CSIC researcher Lluis Montoliu | M. Vicious
When he talks about CAS protein, he means those tiny molecular scissors. There are different types. There are real motorized clippers, called CAS9, that can cut the double strand of DNA. So they are as promising as they are disputed: they work on humans.
For an RNA virus (the chain is simple) a manual scissor pruner is enough, to continue with the metaphor. This is where CAS13a or CAS13d enter. They work (thanks to some guides) no matter what strain, variant, or mutant. Interesting, in case the coronavirus begins to change more than it seems, as it happens with the influenza virus.
The small drawback of these scissors (the CAS13a we have hardly known since 2016) is that once they cut the virus, they can be bundled to cut the rest of the cell. When Dr. Feng Zhang (BROAD / MIT), its inventor tested CAS13a for the first time, he saw that it was doing its job well but immediately freaked out and started cutting, unspecifically, the rest of the RNA in that test tube.
Fortunately, the protein has become more sophisticated so that, already with variant 13d, we have a very specific tool, because the cell has its own RNA and we do not have to touch those, they are useful for it to function.
It also wont enter the nucleus of the human cell (DNA) because CAS13d doesnt need it. That would be as risky as driving the chainsaw into the heart of a hedge. There is a risk of cutting it down.
CAS9, used to edit girls from a tomato, is like that chainsaw, hence the delicacy and prematureness of this technique for editing people. The mess of the cellular patchwork that can be mounted is important, until the gluing technique is fine-tuned, although it shows promise. That is, we are controlling the grafting technique, to continue with the garden comparison.
Regarding the coronavirus, this does not mean that we already have a ready-to-use medicine from these CRISPR scissors. First you will have to check if they work In zebrafish embryos, that we will try Seville, where we will deliver together with CAS13 a guide that tells you where you have to cut .
Then it will be tested in laboratory cells infected with other cousin viruses to avoid risks and we will get their cutting patterns. Hence, yes, in the SARS-CoV-2.
Sure we could start doing the experiment on mice, but its very important that lets go step by step Montoliu warns. At least, with the certainty that the method works in cells outside a living being
The project has received 75,000 euros of financing from donations from companies and individuals. When we have verified that it works in cells, we will test it in mice (also edited), after this year. If we see (this year) that we can degrade SARS-CoV-2 in crops it would already be a success.
In April, after theoretical proposals in this regard, researchers from Stanford and Duke universities developed a curative scissors of this type, experimentally viable in human lung cells. They named it PACMAN (Comecocos). Will it work outside the lab loft?
CAS scissors can cut viruses. And if they do, it is because they detect them, so it is possible to use them to do tests, in theory.
Although, to date, the most reliable method to detect the active virus in a person is RT-PCR, exist other genetic screening approaches which have not yet been shown to work, but which are promising. This is the case of this possible pocket PCR, in which Margarita Salas Luis Blancos patent partner works.
The CRISPR genetic cutter can also aid in the detection of coronaviruses. In classic PCR methods and that of Blancos team, the virus is evident because it literally shines in the laboratory. With CRISPR it is possible to shine each cut that scissors, CAS12 in this case, they hit the gene molecule.
There are several methods to experiment with, under the acronyms SHERLOCK and CARMEN. The interesting thing about these technologies is that, combined, they can perform hundreds of tests simultaneously. And not only for detecting SARS-CoV-2, but for 120 different viruses.
CARMEN Test Plate | Michel James, MIT
These are some of the applications of genetic engineering to destroy viruses or to immunize ourselves against them, since there are several biotechnological approaches in the race for the COVID-19 vaccine that involve the manipulation of genes (of the virus, in this case).
Cut. Paste. And create new viruses. Again, and in the sense of some conspiracy theories, We do have the methodology to (rather than destroy) make viruses, but we dont have the intellectual capacity , responds the head of the virology laboratory at Cambridge University Nerea Irigoyen.
There is methodology, not capacity, to create a laboratory virus, but SARS-CoV-2 is far from being the perfect pandemic virus.
He remembers comments on social networks in which he was told that viruses mutate in laboratories. Indeed, Ive been doing it for many years. But it is one thing to do it and quite another to make a perfect pandemic virus. This is not it. We could still do much better so that it could infect more cell types.
70% of human infectious diseases come from viruses, bacteria, or animal parasites. It has always happened. Flu, Ebola, SARS-1, MERS Why dont we accept the normal?, Concludes the scientist.
Read the original post:
Cut and paste: the true genetic engineering of the coronavirus - Explica
- genetic engineering summary | Britannica - September 13th, 2024
- The great gene editing debate: can it be safe and ethical? - BBC.com - September 13th, 2024
- Anti-biotechnology campaigners embrace classic crops, are suspicious of hybrid varieties and claim genetic modification violates nature. Heres a... - September 13th, 2024
- Will IL-11 Control Extend Human Life One Day? Early Results are Tantalizing - Securities.io - September 13th, 2024
- Viewpoint: As New Zealand edges toward relaxing its ban on gene edited foods, experts weigh in - Genetic Literacy Project - September 13th, 2024
- Farmers in Brazil and Argentina ramp up growing of genetically-modified drought tolerant wheat that can grow in subtropical regions - Genetic Literacy... - September 13th, 2024
- Scientist explains why we'll never have a real Jurassic Park - and people are crestfallen - indy100 - September 13th, 2024
- Genetic engineering techniques - Wikipedia - January 9th, 2024
- 20.3: Genetic Engineering - Biology LibreTexts - January 9th, 2024
- Genetic engineering - DNA Modification, Cloning, Gene Splicing - December 13th, 2023
- Global Gene Editing Market Poised for Significant Growth, Projected to Reach $14.28 Billion by 2027 - EIN News - December 13th, 2023
- Principles of Genetic Engineering - PMC - National Center for ... - May 17th, 2023
- Quitting: A Life Strategy: The Myth of Perseveranceand How the New Science of Giving Up Can Set You Free - Next Big Idea Club Magazine - May 17th, 2023
- 18 Human Genetic Engineering - Clemson University - March 29th, 2023
- Pros and Cons of Genetic Engineering - Benefits and Risks - March 29th, 2023
- How artificial skin is made and its uses, from treating burns to skin cancer - South China Morning Post - March 29th, 2023
- Genetic Engineering - Meaning, Applications, Advantages and Challenges ... - March 13th, 2023
- Revolutionary Specialty Enzymes Transform Industries, Projected to Reach $2.2 Billion by 2031 - Billion-Dollar - EIN News - March 5th, 2023
- Explained: What is genome editing technology and how is it different from GM technology? - The Indian Express - April 2nd, 2022
- Scribe Therapeutics to Participate in Upcoming Goldman Sachs The New Guard: Privates Leading the Disruption in Healthcare Investor Conference - Yahoo... - April 2nd, 2022
- San Antonio Zoo In Discussions on Woolly Mammoth Project - iHeart - April 2nd, 2022
- Xenotransplantation trials will require adjusting expectations, experts say - STAT - April 2nd, 2022
- 5 Interesting Startup Deals You May Have Missed In March: Restoring The Woolly Mammoth, Faux Seafood And Lots Of Bees - Crunchbase News - April 2nd, 2022
- Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for ... - KULR-TV - April 2nd, 2022
- The Bay Area food tech industry is creating more than vegan burgers. Heres whats next - San Francisco Chronicle - April 2nd, 2022
- Student Startup Teams to Compete For $110000 Cash Prize Pool in U of A's Heartland Challenge - University of Arkansas Newswire - April 2nd, 2022
- Should we test for differences in allergen content between varieties of crops and animal species? - Open Access Government - April 2nd, 2022
- Genetic Engineering - Courses, Subjects, Eligibility ... - December 22nd, 2021
- Scientists Used CRISPR Gene Editing to Choose the Sex of Mouse Pups - Singularity Hub - December 22nd, 2021
- Report calls for broad public deliberation on releasing gene-edited species in the wild - EurekAlert - December 22nd, 2021
- RNA and DNA Extraction Kit Market Study | Know the Post-Pandemic Scenario of the Industry - BioSpace - December 22nd, 2021
- Opinion: Allow Golden Rice to save lives - pnas.org - December 22nd, 2021
- It's time for an alliance of democracies | TheHill - The Hill - December 22nd, 2021
- Aridis Pharmaceuticals Announces a Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19... - December 22nd, 2021
- 2021: when the link between the climate and biodiversity crises became clear - The Guardian - December 22nd, 2021
- Wuhan lab leak now the most likely cause of Covid pandemic and the truth WILL come out, experts tell MPs... - The US Sun - December 22nd, 2021
- Biotech ETFs That Outperformed Last Week - Yahoo Finance - December 22nd, 2021
- Human genetic enhancement - Wikipedia - October 5th, 2021
- Viewpoint: Part 1 Opposition stirred by anti-GMO advocacy group propaganda fading in the developing world, as more countries embrace crop... - October 5th, 2021
- Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx Genome Engineering Platform - WWNY - October 5th, 2021
- Kingdom Supercultures raises $25m to expand Non GMO suite of microbes to unlock new flavors, textures, and functionalities in food & beverage -... - October 5th, 2021
- Fact check: Genetically engineering your salad with the COVID-19 vaccines? We're not there yet. - USA TODAY - October 5th, 2021
- Making the Transition from an Academic to a Biobusiness Entrepreneur - Genetic Engineering & Biotechnology News - October 5th, 2021
- Is The New York Times Finally 'Learning To Love GMOS'? - American Council on Science and Health - October 5th, 2021
- Gene editing, joke theft and manifesting - The Week UK - October 5th, 2021
- Opinion: Saving lives through real social justice - Agri-Pulse - October 5th, 2021
- Science, business and the humanities: CP Snow's 'Two Cultures' sixty years on - TheArticle - October 5th, 2021
- Probiotic Yeast Engineered To Produce Beta-Carotene - Technology Networks - April 17th, 2021
- In the US, Imminent Release of Genetically Modified Mosquitoes To Fight Dengue - The Wire Science - April 17th, 2021
- CRISPRoff: A New Addition to the CRISPR Toolbox - Technology Networks - April 17th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 17th, 2021
- Grammar of the Genome: Reading the Influence of DNA on Disease - Baylor University - April 17th, 2021
- We cannot let China set the standards for 21st century technologies | TheHill - The Hill - April 17th, 2021
- First GMO Mosquitoes to Be Released in the Florida Keys - Singularity Hub - April 17th, 2021
- Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations - BioSpace - April 17th, 2021
- AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses - OncoZine - April 17th, 2021
- StrideBio Announces a Multi-technology License and Master SRA with Duke University to Advance Next-generation Gene Therapies - BioSpace - April 17th, 2021
- ThermoGenesis : The History of Cell and Gene Therapy - marketscreener.com - April 17th, 2021
- EU's refusal to permit GMO crops led to millions of tonnes of additional CO2, scientists reveal - Alliance for Science - Alliance for Science - February 14th, 2021
- New species of fly named after Singanallur Tank - The Hindu - February 14th, 2021
- Son of Monarchs Pays Homage to the Beauty of Migration - Sierra Magazine - February 14th, 2021
- Podcast: TIME's 2020 Kid of the Year, Gitanjali Rao - All Together - Society of Women Engineers - February 14th, 2021
- Geoengineering: What could possibly go wrong? Elizabeth Kolbert's take, in her new book - Bulletin of the Atomic Scientists - February 14th, 2021
- An Introduction to PCR - Technology Networks - February 14th, 2021
- Science Talk - Evolution, cancer and coronavirus how biology's 'Theory of Everything' is key to fighting cancer and global pandemics - The Institute... - February 14th, 2021
- 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with... - February 14th, 2021
- Aleph Farms and The Technion Reveal World's First Cultivated Ribeye Steak - PRNewswire - February 9th, 2021
- Researchers create rice that captures more CO2 with 30 percent more yield - FoodIngredientsFirst - February 9th, 2021
- Interview: Elizabeth Kolbert on why well never stop messing with nature - Grist - February 9th, 2021
- Is Biotechnology the Answer to a More Sustainable Beauty Industry? - Fashionista - February 9th, 2021
- New Jersey arts and entertainment news, features, and event previews. - New Jersey Stage - February 9th, 2021
- CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft... - February 9th, 2021
- Taysha Gene Therapies Announces Collaborations to Advance Next-Generation Mini-Gene Payloads for AAV Gene Therapies for the Treatment of Genetic... - February 9th, 2021
- A new tool to investigate bacteria behind hospital infections - MIT News - February 9th, 2021
- Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts - GlobeNewswire - February 9th, 2021
- Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization - GlobeNewswire - February 9th, 2021
- Global Lab-On-A-Chip Market Industry Perspective, Comprehensive Analysis, and Forecast 2027||Players-Perkin Elmer Corporation, IDEX, Thermo Fisher... - February 9th, 2021
- Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium - PharmiWeb.com - February 9th, 2021
- Global Bacterial and Plasmid Vectors Market Report 2020: Market is Expected to Recover and Reach $0520 Million in 2023 at a CAGR of 15.48% - Forecast... - January 12th, 2021
- mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry - TIME - January 12th, 2021